The trademark application APONVIE was filed by Heron Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 7, 2022, and it was registered by office on February 14, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Anti-emetic pharmaceutical preparations
Pharmaceutical preparations for the management of nausea and vomiting
Pharmaceutical preparations for the management of post-operative nausea and vomiting
Pharmaceutical preparations for the management of side effects of surgery
Pharmaceutical preparations associated with surgery
Nausea treatment preparations
Pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting
Pharmaceutical preparations for the management of cancer treatment side effects
Pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy.
The mark was filed in class 42 with following description of goods:
Providing scientific and medical research information in the field of pharmaceuticals and clinical trials
Pharmaceutical research and development services
Product research and development services.
The mark was filed in class 44 with following description of goods:
Providing medical and healthcare information to medical professionals in the fields of oncology and pain management